News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,895 Results
Type
Article (39143)
Company Profile (283)
Press Release (648469)
Section
Business (203901)
Career Advice (1996)
Deals (35371)
Drug Delivery (89)
Drug Development (80846)
Employer Resources (168)
FDA (16098)
Job Trends (14808)
News (344639)
Policy (32450)
Tag
Academia (2530)
Alliances (49183)
Alzheimer's disease (1257)
Approvals (16049)
Artificial intelligence (144)
Bankruptcy (352)
Best Places to Work (11581)
Biotechnology (200)
Breast cancer (188)
Cancer (1365)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64692)
Collaboration (482)
Compensation (260)
COVID-19 (2541)
C-suite (108)
Data (1389)
Diabetes (172)
Diagnostics (6170)
Earnings (84892)
Employer resources (146)
Events (110005)
Executive appointments (394)
FDA (16767)
Funding (426)
Gene therapy (195)
GLP-1 (597)
Government (4333)
Healthcare (18693)
Infectious disease (2633)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16339)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7861)
Lung cancer (197)
Lymphoma (98)
Manufacturing (206)
Medical device (13211)
Medtech (13216)
Mergers & acquisitions (19192)
Metabolic disorders (452)
Neuroscience (1577)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1693)
Obesity (258)
Opinion (183)
Patents (117)
People (56456)
Phase I (20119)
Phase II (28493)
Phase III (21237)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (259)
Real estate (5890)
Regulatory (21664)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1460)
Startups (3562)
United States (15141)
Vaccines (563)
Weight loss (181)
Date
Last 7 days (580)
Last 30 days (2325)
Last 365 days (35163)
2024 (35002)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46542)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (195)
Asia (37266)
Australia (6087)
California (3809)
Canada (1449)
China (304)
Colorado (171)
Connecticut (176)
Europe (79824)
Florida (533)
Georgia (135)
Illinois (384)
Indiana (224)
Maryland (626)
Massachusetts (2959)
Michigan (172)
Minnesota (290)
New Jersey (1100)
New York (1080)
North Carolina (742)
Northern California (1693)
Ohio (146)
Pennsylvania (923)
South America (1091)
Southern California (1460)
Texas (547)
Utah (108)
Washington State (399)
687,895 Results for "neuronetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference
November 20, 2024
·
1 min read
Pharm Country
Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
Neuronetics, Inc. today announced that the management team will present at the William Blair 44th Annual Growth Stock Conference on Thursday, June 6, 2024.
May 23, 2024
·
1 min read
Press Releases
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - December 16, 2024
December 17, 2024
·
4 min read
Press Releases
CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results
November 12, 2024
·
16 min read
Business
Neuronetics Reports Record First Quarter 2024 Financial and Operating Results
Neuronetics, Inc. a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, announced its financial and operating results for the first quarter of 2024.
May 7, 2024
·
15 min read
Press Releases
Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call
October 29, 2024
·
1 min read
Pharm Country
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2024
Neuronetics, Inc. announced the granting of inducement awards of Restricted Stock Units representing a total of 55,650 shares of the Company’s common stock to thirteen new non-executive employees.
May 3, 2024
·
4 min read
Business
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
Neuronetics, Inc. announced an expanded commercial partnership with Transformations Care Network, one of the nation’s largest mental health care providers.
March 7, 2024
·
4 min read
Press Releases
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 12, 2024
November 12, 2024
·
4 min read
Business
Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that it plans to release first quarter 2024 financial and operating results prior to market open on Tuesday, May 7th, 2024.
April 23, 2024
·
1 min read
1 of 68,790
Next
